EPCAM and colonic neoplasm: Therefore, this study’s results suggest that multiple mAbP CO17-1A × BR55 have a significant effect on apoptosis-mediated anticancer by suppression of ERK1/2 phosphorylation in colon cancer compared to anti-EpCAM mAb and mAbP CO17-1A.